Marta O. Soares : Citation Profile

Are you Marta O. Soares?

University of York


H index


i10 index









   7 years (2010 - 2017). See details.
   Cites by year: 10
   Journals where Marta O. Soares has often published
   Relations with other researchers
   Recent citing documents: 15.    Total self citations: 0 (0 %)


   Updated: 2022-06-25    RAS profile: 2018-11-15    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Marta O. Soares.

Is cited by:

Claxton, Karl (5)

Devlin, Nancy (5)

Karlsberg Schaffer, Sarah (4)

Brouwer, Werner (4)

Karlsberg, Sarah (4)

Sculpher, Mark (4)

Asaria, Miqdad (3)

Revill, Paul (3)

Svensson, Mikael (2)

Culyer, Anthony (2)

Brazier, John (2)

Cites to:

Claxton, Karl (8)

McCabe, Christopher (5)

Brazier, John (4)

Sculpher, Mark (4)

Basu, Anirban (2)


Mullahy, John (2)

Culyer, Anthony (1)

Johannesson, Magnus (1)

Main data

Where Marta O. Soares has published?

Journals with more than one article published# docs

Working Papers Series with more than one paper published# docs
Working Papers / Centre for Health Economics, University of York4

Recent works citing Marta O. Soares (2021 and 2020)

YearTitle of citing document
2021Latent Ornstein?Uhlenbeck models for Bayesian analysis of multivariate longitudinal categorical responses. (2021). Duyck, Joke ; Verbeke, Geert ; Lesaffre, Emmanuel ; Tran, Trung Dung. In: Biometrics. RePEc:bla:biomet:v:77:y:2021:i:2:p:689-701.

Full description at Econpapers || Download paper

2021Paying for health gains. (2021). Chalkley, Martin ; Gravelle, Hugh ; Gutacker, Nils ; Gaughan, James ; Siciliani, Luigi. In: Working Papers. RePEc:chy:respap:183cherp.

Full description at Econpapers || Download paper

2021Eliciting a monetary threshold for a year of sufficient capability to inform resource allocation decisions in public health and social care. (2021). Afentou, Nafsika ; Kinghorn, Philip. In: Social Science & Medicine. RePEc:eee:socmed:v:279:y:2021:i:c:s0277953621003099.

Full description at Econpapers || Download paper


Full description at Econpapers || Download paper

2021How Effective is Marginal Healthcare Expenditure? New Evidence from England for 2003/04 to 2012/13. (2021). Martin, Stephen ; Longo, Francesco ; Claxton, Karl ; Lomas, James. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:6:d:10.1007_s40258-021-00663-3.

Full description at Econpapers || Download paper

2020Cost-effectiveness analysis of the Neuropad device as a screening tool for early diabetic peripheral neuropathy. (2020). Rodriguez-Sanchez, B ; Sinclair, A J ; Pea-Longobardo, L M. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:3:d:10.1007_s10198-019-01134-2.

Full description at Econpapers || Download paper

2020Informing a Cost-Effectiveness Threshold for Health Technology Assessment in China: A Marginal Productivity Approach. (2020). Lomas, James ; Gu, Yuanyuan ; Wang, Haiyin ; Ochalek, Jessica ; Jin, Chunlin ; Cutler, Henry. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:12:d:10.1007_s40273-020-00954-y.

Full description at Econpapers || Download paper

2020Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment. (2020). Carlson, Josh J ; Ramsey, Scott D ; Veenstra, David L ; Basu, Anirban ; Bennette, Caroline S ; Guzauskas, Gregory F ; Kim, David D. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:2:d:10.1007_s40273-019-00848-8.

Full description at Econpapers || Download paper

2020How Uncertain is the Survival Extrapolation? A Study of the Impact of Different Parametric Survival Models on Extrapolated Uncertainty About Hazard Functions, Lifetime Mean Survival and Cost Effective. (2020). Brennan, Alan ; Stevens, John ; Kearns, Ben . In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:2:d:10.1007_s40273-019-00853-x.

Full description at Econpapers || Download paper

2020After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator?. (2020). Palmer, Stephen ; Sculpher, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:3:d:10.1007_s40273-019-00882-6.

Full description at Econpapers || Download paper

2021Modifying NICE’s Approach to Equity Weighting. (2021). McCabe, Christopher ; Paulden, Mike. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:2:d:10.1007_s40273-020-00988-2.

Full description at Econpapers || Download paper

2021NICE’s Discounting Review: Clear Thinking on Rational Revision Meets Obstacle of Industrial Interests. (2021). Paulden, Mike ; Omahony, James F ; McCabe, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:2:d:10.1007_s40273-020-00990-8.

Full description at Econpapers || Download paper

2020Is Protocolised Weaning that Includes Early Extubation Onto Non-Invasive Ventilation More Cost Effective Than Protocolised Weaning Without Non-Invasive Ventilation? Findings from the Breathe Study. (2020). Maredza, Mandy ; Khan, Iftekhar ; Petrou, Stavros ; Perkins, Gavin D ; Gates, Simon ; Couper, Keith ; Lamb, Sarah E ; Lall, Ranjit ; Mistry, Dipesh ; Dritsaki, Melina. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:4:d:10.1007_s41669-020-00210-1.

Full description at Econpapers || Download 2020

Economic Tendencies of the European and Latvian Medical Device Market. (2020). Nadezhda, Semjonova. In: Economics and Business. RePEc:vrs:ecobus:v:34:y:2020:i:1:p:297-310:n:20.

Full description at Econpapers || Download paper

2021Estimating optimal willingness to pay thresholds for cost?effectiveness analysis: A generalized method. (2021). Cinatl, Chris ; Phelps, Charles E. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:7:p:1697-1702.

Full description at Econpapers || Download paper

Works by Marta O. Soares:

2014Treatment comparisons for decision making: facing the problems of sparse and few data In: Journal of the Royal Statistical Society Series A.
[Full Text][Citation analysis]
2010Simulation or cohort models? Continuous time simulation and discretized Markov models to estimate cost-effectiveness In: Working Papers.
[Full Text][Citation analysis]
2011Uncertainty, evidence and irrecoverable costs: Informing approval, pricing and research decisions for health technologies In: Working Papers.
[Full Text][Citation analysis]
2013Methods for the estimation of the NICE cost effectiveness threshold In: Working Papers.
[Full Text][Citation analysis]
2014Network Meta-Analysis of (Individual Patient) Time to Event Data Alongside (Aggregate) Count Data In: Working Papers.
[Full Text][Citation analysis]
2012Continuous Time Simulation and Discretized Models for Cost-Effectiveness Analysis In: PharmacoEconomics.
[Full Text][Citation analysis]
2016The Clinical and Cost Effectiveness of Vortioxetine for the Treatment of a Major Depressive Episode in Patients With Failed Prior Antidepressant Therapy: A Critique of the Evidence In: PharmacoEconomics.
[Full Text][Citation analysis]
2017Informing Reimbursement Decisions Using Cost-Effectiveness Modelling: A Guide to the Process of Generating Elicited Priors to Capture Model Uncertainties In: PharmacoEconomics.
[Full Text][Citation analysis]

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated March, 30 2022. Contact: CitEc Team